Clinical trials
27 active studies led by UCB Biopharma SRL, of 129 in all
Source: ClinicalTrials.gov, Studies with UCB Biopharma SRL (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
- 0Reports naming them
- 6Markets in public records
- 0Regions & countries
- 27Active trials they lead[1]
[1] ClinicalTrials.gov, Studies led by UCB Biopharma SRL or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public data on UCB Biopharma SRL
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
See them on ClinicalTrials.gov (opens in a new tab)
Trials over time
Studies UCB Biopharma SRL leads, by the year they started and their phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- No phase (devices, observational)
Source: ClinicalTrials.gov, Studies with UCB Biopharma SRL or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets where public records show them
Markets we cover where free public records show UCB Biopharma SRL: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
Topics
The topics of the markets UCB Biopharma SRL is in.
From our blog
Stories on the topics UCB Biopharma SRL works in.
Collagen Supplements: Skin, Joints and Real Evidence
Collagen powders promise younger skin and easier joints. A 2025 review of 23 trials found the benefits…
Read
Brain Cancer Diagnosis: Imaging and New Biomarkers
About 321,000 people were diagnosed with brain and nervous system tumours in 2022, and about 248,000 died…
Read
Dermatology Diagnostics: AI and Skin Health
Skin cancers caused over 1.5 million new cases in 2022. Imaging and AI tools are changing how skin conditions…
Read